- Home
- TRVI vs AVNS Comparison
TRVI vs AVNS Comparison
Compare TRVI & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRVI
- AVNS
- Stock Information
- Founded
- TRVI 2011
- AVNS 2014
- Country
- TRVI United States
- AVNS United States
- Employees
- TRVI N/A
- AVNS N/A
- Industry
- TRVI Biotechnology: Pharmaceutical Preparations
- AVNS Industrial Specialties
- Sector
- TRVI Health Care
- AVNS Health Care
- Exchange
- TRVI Nasdaq
- AVNS Nasdaq
- Market Cap
- TRVI 629.8M
- AVNS 591.9M
- IPO Year
- TRVI 2019
- AVNS N/A
- Fundamental
- Price
- TRVI $5.96
- AVNS $12.15
- Analyst Decision
- TRVI Strong Buy
- AVNS
- Analyst Count
- TRVI 8
- AVNS 0
- Target Price
- TRVI $19.31
- AVNS N/A
- AVG Volume (30 Days)
- TRVI 2.6M
- AVNS 421.7K
- Earning Date
- TRVI 08-07-2025
- AVNS 07-30-2025
- Dividend Yield
- TRVI N/A
- AVNS N/A
- EPS Growth
- TRVI N/A
- AVNS N/A
- EPS
- TRVI N/A
- AVNS N/A
- Revenue
- TRVI N/A
- AVNS $689,200,000.00
- Revenue This Year
- TRVI N/A
- AVNS N/A
- Revenue Next Year
- TRVI N/A
- AVNS $3.42
- P/E Ratio
- TRVI N/A
- AVNS N/A
- Revenue Growth
- TRVI N/A
- AVNS 1.34
- 52 Week Low
- TRVI $2.36
- AVNS $11.84
- 52 Week High
- TRVI $7.48
- AVNS $25.36
- Technical
- Relative Strength Index (RSI)
- TRVI 43.31
- AVNS 44.36
- Support Level
- TRVI $6.05
- AVNS $12.00
- Resistance Level
- TRVI $6.49
- AVNS $12.33
- Average True Range (ATR)
- TRVI 0.53
- AVNS 0.35
- MACD
- TRVI -0.05
- AVNS -0.03
- Stochastic Oscillator
- TRVI 27.62
- AVNS 21.49
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.
About AVNS Avanos Medical Inc.
Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.